NCT00294125View on ClinicalTrials.gov

Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Osteoarthritis

Interventions

DRUG

Flavocoxid

Daily flavocoxid for 12 weeks

DRUG

Placebo

Daily placebo for 12 weeks

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

Primus Pharmaceuticals

All Listed Sponsors

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Primus Pharmaceuticals

INDUSTRY

lead

University of Alabama at Birmingham

OTHER